Navigation Links
WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation
Date:11/14/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...Dec. 2 Peregrine Pharmac...pletion of patient enrollment in a dose confirmati... with relapsed glioblastoma multiforme (GBM), the ...ted monoclonal antibody linked to a radioisotope b...M. Cotara specifically targets cells at the cente...
(Date:12/2/2009)...bon, December 2 , - "Bols...and Heritage" , Coinciding with the Inter...abonese Republic is hosting an international confe...arding biological resources in Africa. The,confere...rs, ministers,scientific experts, private compani...
(Date:12/2/2009)...ss., Dec. 2 TechConnect World, an ...development and product integration in cleantech, ... 11th deadline for technology abstracts and busine...Connect World, in association with the Nano Scienc...echnology and Sustainable Industries Organization ...
(Date:12/2/2009)...c. 2 S*BIO Pte Ltd today announced...or, SB1518, at The American Society of Hematology ... ,, Data will be presented on the clinical resu...18 detailing its safety, tolerability and pharmaco...vels ranging from 100 to 600 mg. These doses were ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
..., PHILADELPHIA, March 25 In an economic environme...p challenges, Prime Health Network and its patient...ing InstaMed,s industry leading healthcare payment...ncreased patient collections and reduced their cos...e patient experience at each of their eleven locat...
..., DUBLIN, March 25 Shire plc (LSE: SHP, NASDA...al company, announces that its,Annual Report and A...2008 has,been published on its website. Shire has ...lts, prepared in accordance with US generally acce...ngs announcement on February 19,2009. , Copies...
..., NOVATO, Calif., March 25 BioMarin Pharmaceutica...-Jacques Bienaime, Chief Executive Officer of BioM...ual Citi Biotech Day in New York City on Wednesday...arties may access a live audio webcast of the conf...in website, www.BMRN.com . A replay of the call ...
Other Biology Technology:Prime Health Network and Its Patients Thrive in Tough Economic Times on the InstaMed Network 2Prime Health Network and Its Patients Thrive in Tough Economic Times on the InstaMed Network 3Publication of Shire plc's Annual Report 2008 2Publication of Shire plc's Annual Report 2008 3Publication of Shire plc's Annual Report 2008 4Publication of Shire plc's Annual Report 2008 5Publication of Shire plc's Annual Report 2008 6Publication of Shire plc's Annual Report 2008 7Publication of Shire plc's Annual Report 2008 8Publication of Shire plc's Annual Report 2008 9Publication of Shire plc's Annual Report 2008 10Publication of Shire plc's Annual Report 2008 11Publication of Shire plc's Annual Report 2008 12Publication of Shire plc's Annual Report 2008 13Publication of Shire plc's Annual Report 2008 14Publication of Shire plc's Annual Report 2008 15Publication of Shire plc's Annual Report 2008 16Publication of Shire plc's Annual Report 2008 17Publication of Shire plc's Annual Report 2008 18Publication of Shire plc's Annual Report 2008 19Publication of Shire plc's Annual Report 2008 20Publication of Shire plc's Annual Report 2008 21Publication of Shire plc's Annual Report 2008 22Publication of Shire plc's Annual Report 2008 23Publication of Shire plc's Annual Report 2008 24Publication of Shire plc's Annual Report 2008 25Publication of Shire plc's Annual Report 2008 26Publication of Shire plc's Annual Report 2008 27Publication of Shire plc's Annual Report 2008 28Publication of Shire plc's Annual Report 2008 29Publication of Shire plc's Annual Report 2008 30Publication of Shire plc's Annual Report 2008 31Publication of Shire plc's Annual Report 2008 32Publication of Shire plc's Annual Report 2008 33BioMarin to Present at the 4th Annual Citi Biotech Day 2
(Date:12/3/2009)...s to investment in energy efficient technologies r...earch Council (EPSRC) Chief Executive Dave Delpy b...eering research has already brought us fuel cells,...investment is needed to develop the capabilities o... emission targets by 2020 and limit the impact of ...
(Date:12/2/2009)... Latino men have a more difficult time quitting sm... culture, but acculturation has no affect on Latin...ings are published in Cancer Epidemiology, Biomar...ciation for Cancer Research. The December issue ha...ffects smoking cessation differently for Latino me...
(Date:12/2/2009)...olescents exposed to cigarette smoking scenes in m...ves, and this may be part of the acculturation pro... to new study findings. , "Our study supports an...hlights the global implementation of the World Hea...ontrol, which includes guidelines for countries to...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Acculturation affects smoking cessation success among Latinos 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation 5676 1Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation 5676 2Survival after heart attack improves in younger women 60050 1Survival after heart attack improves in younger women 60050 2Cell Therapeutics Inc 28CTI 29 to Present at 8th Annual BIO Investor Forum 5673 1
...The results of a national survey released by PGAV ... in the international entertainment, tourism and h...orld-renowned Missouri Botanical Garden, reveal an...and perceptions regarding environmentally sustaina...d by Jerry Henry & Associates and called "Survival...
...ionary history of diatoms -- abundant oceanic plan...e from the air each year -- needs to be rewritten,...ggest that after a sudden rise in species numbers,...ago -- trends that coincided with severe global co...e of the journal Nature . , The research casts do...
...n the international journal Neurobiology of Aging...sically fit helps the brain function at the top of...cal Research Senior Scholar, Poulin finds that phy...nd, as a result, cognitive abilities. , "Being se... and dementia," says Poulin, a scientist in the Fa...
Other Biology News:Landmark national study reveals significance of green practices in attractions industry 2Decline of carbon-dioxide-gobbling plankton coincided with ancient global cooling 2Research finds older women who are more physically fit have better cognitive function 2
MetaMorph from Universal Imaging Corporation (a subsidiary of Molecular Devices)
...olecular Devices is a fully-integrated true point-... and analysis of images for high throughput cell-b...taXpress, a complete software solution for screeni...ress enables users to select a standard image anal...
Varian 2200 Ion Trap GC/MS from Varian, Inc.
... quantification of the green complex formed betwee...te. The rapid color formation from the reaction ca...(600-660 nm) or on a plate reader. The non-radioac...o offer superior sensitivity and prolonged shelf l...
Biology Products: